Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Pfizer Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones, cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under...
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITD.
Target Price
The average target price of PFIZER.NS is 6851 and suggests 46% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i
Buy
Sell